The team heading to ISPOR 2026
Quantify Research will be attending ISPOR 2026 in Philadelphia (17–20 May) as part of the athagoras Group.
Joining from Quantify:
• Puneet Kaushik
• Kelsi Smith
• Abraham Choong
4
May 2026
1
May 2026
Rare disease HTA: TLV accepts an ICER above 2 million SEK/QALY
TLV’s recent decision on Fabhalta provides further evidence of how Sweden applies higher acceptable ICERs in very rare conditions.
Fabhalta was assessed for a very rare, severe chronic kidney disease population. Following three-party negotiations, TLV’s base case, including the confidential agreement, […]
29
Apr 2026
TLV postpones guideline updates
The Swedish HTA agency TLV has announced changes to the timeline and content of its upcoming guidance on reimbursement and pricing of medicines.
Key points from the update:
📍The previously communicated timeline has been postponed. The revised guidance will enter into force […]
23
Apr 2026
🟢Day 2- beyond pharmacoeconomics
Day 2 at SHEA highlighted a broader perspective: health economics extends well beyond traditional pharmacoeconomic frameworks.
Discussions included applications across:
📍social care alongside healthcare
📍the health economic value of green outdoor environments
Closer to our core areas, two themes stood out:
➡️ the continued importance […]
23
Apr 2026
🔹SHEA Day 1 – Navigating HTA under pressure
Day 1 in Lund highlighted a clear direction: global policy shifts are increasingly shaping local HTA realities.
External changes, including US MFN policy, are already influencing the pharmaceutical landscape beyond their origin.
Less than a year on, the impact feels well embedded.
At […]
21
Apr 2026
Top-cited methods in Pharmacoepidemiology
Choosing the right study design for the causal question
We are proud to share that a paper co-authored by Jessica Young is among the Top 10 most-cited papers in Pharmacoepidemiology and Drug Safety for 2024.
The paper, “Core Concepts in Pharmacoepidemiology: New-User Designs,” explores how […]
10
Apr 2026
Evidence Expertise
Expanding our Evidence, Review & Synthesis team
We are pleased to welcome Dr. Gulchehak Kaur to Quantify Research.
Gulchehak joins our Evidence, Review and Synthesis team with a strong foundation across clinical and economic disciplines:
📓Undergraduate degree in Dentistry
📓MSc in Health Economics, Manipal […]
1
Apr 2026
👥 Team growth
We are pleased to welcome Sami Gabbouj to Quantify Research as Project Leader.
Sami brings more than 10 years of experience across the biomedical field, combining scientific depth with business understanding.
His approach reflects a core challenge in our field:
➡️ translating clinical […]
23
Mar 2026
Welcome Emilia!
We are pleased to welcome Emilia Larsson to Quantify Research as Senior HR Business Partner.
Emilia brings ~8 years of HR experience across international organisations in tech, medtech, healthcare, and life sciences.
Her background includes:
• […]
12
Mar 2026
RWD is only the start. How is it used in regulatory evidence?
After exploring real-world data sources across the Nordic countries, we now pivot to how this data is used in regulatory evidence generation.
One important example is Post-Authorisation safety Studies (PASS).
The PASS framework is specific to the European Union regulatory system.
Other regulators, […]